Результати пошуку - Anghel Adrian Udrea

  • Показ 1 - 5 результатів із 5
Уточнити результати
  1. 1
    A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

    A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer за авторством Tae Won Kim, Anneli Elme, Zvonko Kusić, Joon Oh Park, Anghel Adrian Udrea, Sun Young Kim, Joong Bae Ahn, Ricardo Villalobos-Valencia, Srinivasan Krishnan, Ante Bilić, Nebojša Manojlović, Jun Dong, Xuesong Guan, Catherine Lofton–Day, A. Scott Jung, Eduard Vrdoljak

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab

    Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab за авторством Charles S. Fuchs, Josep Tabernero, Jiří Tomášek, Ian Chau, Bohuslav Melichar, Howard Safran, Mustapha Tehfé, Filip Dumitru, Э. Э. Топузов, Luís Alberto Schlittler, Anghel Adrian Udrea, William Campbell, Stephen Brincat, Michael Emig, Symantha Melemed, Rebecca R. Hozak, David Ferry, Clover Caldwell, Jaffer A. Ajani

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

    Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study) за авторством Jérôme Fayette, Lori J. Wirth, Cristina Oprean, Anghel Adrian Udrea, Antonio Jimeno, Danny Rischin, Christopher M. Nutting, Paul M. Harari, Tibor Csőszi, Dana Cernea, Paul E. O’Brien, William D. Hanley, Amy V. Kapp, Maria Anderson, Elicia Penuel, Bruce McCall, Andrea Pirzkall, Jan B. Vermorken

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial

    Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, dou... за авторством Daniel V.T. Catenacci, Niall C. Tebbutt, Ірина Давиденко, André M. Murad, Salah‐Eddin Al‐Batran, David H. Ilson, Sergei Tjulandin, Evengy Gotovkin, Bogusława Karaszewska, Igor Bondarenko, Mohamedtaki Abdulaziz Tejani, Anghel Adrian Udrea, Mustapha Tehfé, Ferdinando De Vita, Cheryl Turkington, Rui Tang, Agnes Ang, Yilong Zhang, Tien Hoang, Roger Sidhu, David Cunningham

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

    RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer за авторством David R. Spigel, Afshin Dowlati, Yuanbin Chen, Alejandro Navarro, James Chih‐Hsin Yang, Goran Stojanović, Maria Jové, Patricia Rich, Zoran Andrić, Yi‐Long Wu, Charles M. Rudin, Huanyu Chen, Li Zhang, Stanley M.H. Yeung, Fawzi Benzaghou, Luis Paz‐Ares, Paul A. Bunn, Philip Clingan, Theresa Hayes, Craig Underhill, Wim Demey, Frédéric Forget, Marc Lambrechts, Kristiaan Nackaerts, Fabio André Franke, Alan A. Azambuja, Rodrigo Régnier Chemim Guimarães, Josiane Mourão Dias, Víctor Sacristán Santos, Bruno Cezar de Mendonça Uchôa, Gustavo Vasconcelos Alves, Cláudia Vaz de Melo Sette, Minghong Bi, Jiuwei Cui, Jian Fang, Jianhua Shi, Ke Wang, Zhen Wang, Xinmin Yu, C. Dayen, Laurent Greillier, Gilles Quéré, Alexander Baraniskin, Helge Bischoff, Frank Griesinger, Cornelius F. Waller, Tibor Csőszi, Gabriella Gálffy, Ibolya Laczó, György Losonczy, S. Tehenes, Angelo Delmonte, Alessandro Follador, Halina Batura‐Gabryel, Piotr Centkowski, Iwona Danielewicz, Andrzej Każarnowicz, Rodryg Ramlau, Alina Muntean, Cristina Oprean, Michael Schenker, Cristina Tiut, Anghel Adrian Udrea, Andrei Ungureanu, Nina Karaseva, Nikolay Kislov, Elena Poddubskaya, Irina Rozhkova, Ekaterina Solovyeva, Anastasia Zimina, Zoran Andrić, Vladimir Kovčin, Marina Petrović, Zorica Radojević, Goran Stojanović, SookHee Hong, Sang‐We Kim, Ki Hyeong Lee, Byoung Yong Shim, M. Alonso Garcìa, Antonio Calles, Vanesa Gutiérrez Calderón, Óscar Juan, B. Massuti Sureda, Alejandro Navarro, Ramón Palmero, Luis Paz-Ares Rodríguez, Ching-Liang Ho, Sheng‐Hao Lin, Chien‐Ying Liu, James Chih‐Hsin Yang, İrfan Çiçin, Mahmut Gümüş, Hakan Harputluoğlu, Mustafa Özgüroğlu, S. Seber, Ahmet Sezer, Hryhoriy Adamchuk, Igor Bondarenko, Yevhen Hotko

    Опубліковано 2024
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: